BD
BDX
HealthcareBecton, Dickinson and Company
Medical Instruments & Supplies
Total Trades
36
Unique Traders
6
Purchases / Sales
13/23
News Articles
5
Trading History
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Apr 24, 2026 |  Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $152.14 | N/A | N/A | N/A | |
Apr 13, 2026 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $155.43 | $144.18 | -7.2% | -15.4% | |
Mar 23, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $156.23 | $155.65 | -0.4% | -8.9% | |
Mar 17, 2026 |  Kevin HernR | Stock | Sell | $15,001 - $50,000 | $161.64 | $154.82 | -4.2% | -9.1% | |
Jan 29, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $157.09 | $175.36 | +11.6% | +12.8% | |
Jan 23, 2026 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $157.63 | $184.21 | +16.9% | +16.8% | |
Nov 10, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $141.12 | $154.99 | +9.8% | +8.9% | |
Nov 3, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $137.75 | $150.39 | +9.2% | +9.1% | |
Sep 29, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $142.96 | $141.03 | -1.3% | -4.9% | |
Aug 4, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $176.97 | $187.56 | +6.0% | +4.0% | |
Jun 24, 2025 |  Lisa McClainR | Stock | Sell | $1,001 - $15,000 | $169.72 | $181.65 | +7.0% | +2.5% | |
Jun 17, 2025 | Lisa McClainR | Stock | Buy | $1,001 - $15,000 | $168.11 | $178.95 | +6.4% | +1.0% | |
May 28, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $170.12 | $169.02 | -0.6% | -5.6% | |
May 19, 2025 | Rohit KhannaD | Stock | Buy | $15,001 - $50,000 | $174.09 | $166.77 | -4.2% | -4.6% | |
May 15, 2025 |  Rob BresnahanR | Stock | Buy | $1,001 - $15,000 | $132.32 | $133.07 | +0.6% | -0.5% | |
May 13, 2025 |  Thomas H. KeanR | Stock | Buy | $1,001 - $15,000 | $134.68 | $134.81 | +0.1% | -2.8% | |
Apr 23, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $155.40 | $131.64 | -15.3% | -23.5% | |
Apr 21, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $151.02 | $132.99 | -11.9% | -25.4% | |
Apr 21, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $151.02 | $132.99 | -11.9% | -25.4% | |
Apr 17, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $152.63 | $134.73 | -11.7% | -24.6% | |
Apr 17, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $152.63 | $134.73 | -11.7% | -24.6% | |
Apr 15, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $155.19 | $132.32 | -14.7% | -24.6% | |
Apr 8, 2025 | Rob BresnahanR | Stock | Sell | $1,001 - $15,000 | $154.26 | $129.00 | -16.4% | -30.2% | |
Apr 7, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $157.52 | $128.38 | -18.5% | -29.8% | |
Apr 7, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $157.52 | $128.38 | -18.5% | -29.8% | |
Apr 4, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $159.26 | $129.64 | -18.6% | -30.8% | |
Apr 4, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $159.26 | $129.64 | -18.6% | -30.8% | |
Mar 5, 2025 |  Jefferson ShreveR | Stock | Sell | $15,001 - $50,000 | $172.46 | $160.28 | -7.1% | +6.0% | |
Feb 25, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $177.03 | $176.80 | -0.1% | +4.2% | |
Feb 19, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $175.11 | $177.97 | +1.6% | +9.3% | |
Jan 22, 2025 | Rohit KhannaD | Stock | Buy | $15,001 - $50,000 | $232.88 | $222.61 | -4.4% | -3.3% | |
Dec 18, 2024 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $219.34 | $232.35 | +5.9% | +3.7% | |
Dec 6, 2024 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $214.34 | $223.62 | +4.3% | +6.6% | |
Dec 6, 2024 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $214.34 | $223.62 | +4.3% | +6.6% |
Recent News
Earnings Preview: Becton Dickinson (BDX) Q2 Earnings Expected to Decline
Yahoo-Invalid Date
BD Achieves Excellence in Employee Well‑Being, Earning Top Industry Recognition
Yahoo-Invalid Date
Is It Time To Reconsider Becton Dickinson (BDX) After Its Recent Share Price Weakness?
Yahoo-Invalid Date
BD Reimagines Central Line Insertion, Advancing Leadership in Patient Safety Through Breakthrough Vascular Access Technology
Yahoo-Invalid Date
Becton Dickinson and Company Launches Bd Centrovena One Insertion System
Finnhub-Invalid Date